Tags: US | Merck | Drug | Pipeline

Merck Has 40 Drugs in Key Stages After Schering Deal

Monday, 01 Mar 2010 11:22 AM

Drugmaker Merck & Co. says it now has about 40 experimental drugs in mid-or late-stage development as a result of its recent deal to buy New Jersey neighbor Schering-Plough Corp.

The combined company also has four drugs awaiting approval by regulators. Those include Schering-Plough medicines for asthma, schizophrenia and contraception, and a Merck drug for a dangerous irregular heartbeat.

The drugs in late-stage development include four treatments for heart disease, an injection for dangerous staph infections and a pill — instead of the shots now used — to gradually cut allergy symptoms in those with hay fever.

Merck, based in Whitehouse Station, N.J., says its integration of the two company's pipelines saw overlap in research programs.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
Markets
Drugmaker Merck Co. says it now has about 40 experimental drugs in mid-or late-stage development as a result of its recent deal to buy New Jersey neighbor Schering-Plough Corp.The combined company also has four drugs awaiting approval by regulators. Those include...
US,Merck,Drug,Pipeline
114
2010-22-01
Monday, 01 Mar 2010 11:22 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved